financing

News

Mendaera's $73m raise heads digital financings

Recent financings in the digital health sector include a $73 million round for artificial intelligence-enabled robotics player Mendaera, with Qure.ai, VieCure, Rippl, and Univa Health also

News

Vicebio raises $100m for vaccines and other bio financings

Our periodic round-up of financings in the biotech sector is led by an impressive nine-figure round for UK vaccines developer Vicebio, with GC Therapeutics, Genespire, and 858 Therapeutics

News

Kristen Fortney, CEO and co-founder of BioAge Labs

Obesity drug developer BioAge raises $198m in IPO

BioAge Labs has completed its upsized initial public offering (IPO), raising $198 million after increasing the number of shares on offer by 40%.

News

Respiratory biotech Upstream joins Nasdaq IPO surge

Upstream Bio has become the latest biotech to chance its arm with a public listing in the US, hoping to raise funds for inflammatory respiratory disease therapy verekitug.

News

US puts $25m behind Cellino's cell and tissue printing tech

Cellino Biotech has received funding from the US government to develop a scalable biomanufacturing platform for personalised regenerative medicines derived from patients' own stem cells.

News

Armed with $100m funding, F2G prepares to refile antifungal

UK biotech F2G has raised $100 million as it prepares to refile its olorofim candidate for invasive fungal infections, which was turned down last year by the FDA.

Mendaera's $73m raise heads digital financings

Vicebio raises $100m for vaccines and other bio financings

Obesity drug developer BioAge raises $198m in IPO

Respiratory biotech Upstream joins Nasdaq IPO surge

US puts $25m behind Cellino's cell and tissue printing tech

Armed with $100m funding, F2G prepares to refile antifungal

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

financing

Editor's Picks